BIOLOGICAL INTELLIGENCE
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 90501374
- Registration number
- 8285219
- Mark type
- Word mark
- Filed
- 01 Feb 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 02 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- Francis P. Cislak
Goods and services
- Class 001 — Chemicals: biochemical, namely, monoclonal antibodies for use in scientific and medical research
- Class 031 — Natural agricultural products: live laboratory animals
Owner
- OMNIAB, INC., Emeryville, CA, US
- OMNIAB, INC., Emeryville, CA, US
- Open Monoclonal Technology, Inc., Emeryville, CA, US
- Open Monoclonal Technology, Inc., Emeryville, CA, US
Prosecution history
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 May 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 May 2026 — EXAMINER'S AMENDMENT ENTERED
- 11 May 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 May 2026 — EXAMINERS AMENDMENT E-MAILED
- 11 May 2026 — SU-EXAMINER'S AMENDMENT WRITTEN
- 08 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 27 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Oct 2025 — FINAL REFUSAL E-MAILED
- 27 Oct 2025 — SU - FINAL REFUSAL - WRITTEN
- 24 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE